Coronary endarterectomy and stent removal in patients with in-stent restenosis

Toshihiro Fukui1, Shuichiro Takanashi, Yasuyuki Hosoda

  • 1Department of Cardiovascular Surgery, Shin-Tokyo Hospital, Matsudo City, Chiba, Japan. tm-fukui@gem.hi-ho.ne.jp

Insights

Coronary endarterectomy and stent removal with LIMA patch grafting is a safe and effective treatment for in-stent restenosis (ISR) involving diffuse disease. This aggressive surgical approach offers a viable option for complex ISR cases.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Biology

Background:

  • In-stent restenosis (ISR) is a significant complication following coronary stent implantation.
  • Current treatment options for ISR are debated, necessitating innovative surgical strategies.
  • Aggressive surgical techniques like endarterectomy and stent removal have been developed for complex ISR cases.

Purpose of the Study:

  • To evaluate the safety and efficacy of coronary endarterectomy and stent removal with concomitant coronary artery bypass grafting (CABG) in patients with severe ISR.
  • To assess the feasibility of using the left internal mammary artery (LIMA) as an on-lay patch for reconstruction in this setting.

Main Methods:

  • Retrospective analysis of 11 consecutive patients with severe ISR treated between April 2001 and March 2004.
  • Patients underwent coronary endarterectomy, stent removal, and multivessel CABG, with LIMA used as an on-lay patch.
  • Data included patient demographics, procedural details, and post-procedure outcomes.

Main Results:

  • All 11 patients underwent successful procedures with no in-hospital complications, except for one case of low output syndrome.
  • The target vessel was the left anterior descending artery (LAD) in all patients.
  • Post-procedure angiography confirmed patency of LIMA patches and LAD arteries, with preserved left ventricular function.

Conclusions:

  • Coronary endarterectomy and stent removal, augmented with an on-lay LIMA patch, represent a safe and effective surgical technique.
  • This approach is particularly beneficial for managing ISR characterized by diffuse target vessel disease.
  • The study highlights a viable surgical option for complex ISR cases refractory to conventional treatments.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...